Skip to main content

Table 1 Patients’ list and clinical outcome

From: Transarterial embolization (TAE) of sacral giant cell Tumor (GCT) using spherical parmanent embolic material superabsorbant polymer microsphere (SAP-MS)

Case

Age

Gender

Previous Tr.

Additional Tr.

Session of TAEs

Follow-up(M)

ISOLS score

Radiographic change

Vs

Tumor size(cm)

Volume change (%)

Reossification

Embolized arteries

Before TAE

After TAE

Before TAE

After TAE

1

30

M

RT 50 Gy 3 M before initial TAE

 

3

118

17%

93%

9 × 9 × 7

5 × 5 × 4

-82.4

(+)

Bil. LSAs, Lt-5th LA

Alive

2

68

F

 

RT 50 Gy 3 M after final TAE

3

141

17%

80%

9 × 9 × 8

6 × 6 × 4

-77.8

(+)

Bil. LSAs

Alive

3

40

F

  

4

39

33%

96%

12 × 10 × 10

9 × 7 × 9

-52.3

(+)

Bil. LSAs

Alive

4

32

M

Curretage 6 M before initial TAE

 

5

14

46%

died

7 × 7 × 9

9 × 12 × 18

340.8

(-)

Bil. LSAs

DOD

  1. Tr. = treatment, RT = radiation therapy, M = months.
  2. average (case1-3) = 99.3, M = months.
  3. average (case1-3) = -70.8.
  4. LSA = Lateral sacral artery, LA = Lumbar artery, Bi. = bilateral.
  5. Vs = Vital status.